Glenmark Pharmaceuticals has decided to stop marketing pesticide products due to dismal market conditions.
The Rs 267 crore company, whose pharma division contributes around Rs 234 crore from domestic sales, has also decided to lease out the pesticide manufacturing unit to reduce the fixed cost of operations.
The pesticide division
